Dementia of the Alzheimer's type uncomplicated

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Erythropoietin analogue 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Inmune Bio Inc. Commercial
    PEGIPANERMIN
    2023-505396-71-00 6 countries 2024 n=127
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Inmune Bio Inc. Commercial 1 Phase II 0
New trials by year
2024
1
← All indication landscapes